opaganib for mcrpc after abiraterone or enzalutamide
Published 3 years ago • 215 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
9:59
profound performance: olaparib vs. enzalutamide or abiraterone for hrr altered mcrpc
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
0:46
ctc hoxb13 rna in mcrpc: abiraterone/enzalutamide impact
-
2:26
caspar: the addition of rucaparib to enzalutamide for the treatment of mcrpc
-
3:14
treatment with abiraterone acetate without steroids in mcrpc
-
1:20
panther: apalutamide abiraterone in black and white mcrpc patients
-
3:44
updates from the cheiron study: docetaxel plus enzalutamide for mcrpc
-
7:09
overall survival with abiraterone acetate plus prednisone in peace-1
-
25:31
management of advanced hormone-sensitive and castration-resistant prostate cancer
-
5:19
xtandi patient stories
-
1:12
dr. pal on sequencing abiraterone and enzalutamide in mcrpc
-
2:45
trial of lhrha, abiraterone and enzalutamide: filling an unmet need in prostate cancer therapy
-
4:35
support for continuing enzalutamide after mcrpc progression | axel merseburger
-
2:19
tomasz m. beer md, facp, on the efficacy of abiraterone enzalutamide in mcrpc
-
3:37
radium-223 after abiraterone: symptomatic skeletal events in patients with mcrpc
-
2:09
dr. charles ryan discusses abiraterone and enzalutamide for mcrpc
-
2:49
overall survival data in mcrpc
-
6:49
ramp: phase ib study of rucaparib & enzalutamide in mcrpc
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
1:37
olaparib plus abiraterone for mcrpc: are biomarkers necessary?
-
2:39
prospects and progress of treatments for mcrpc